Akinori Nagamitsu

615 total citations
11 papers, 482 citations indexed

About

Akinori Nagamitsu is a scholar working on Cancer Research, Biomaterials and Hepatology. According to data from OpenAlex, Akinori Nagamitsu has authored 11 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Biomaterials and 5 papers in Hepatology. Recurrent topics in Akinori Nagamitsu's work include Cancer, Hypoxia, and Metabolism (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Akinori Nagamitsu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Akinori Nagamitsu collaborates with scholars based in Japan and United States. Akinori Nagamitsu's co-authors include Khaled Greish, Hiroshi Maeda, Jun Fang, T Konno, N Kitamura, Yasuji Ishimaru, Tetsuya Oda, Toshimitsu Konno, Masami Kimura and Michio Kawasuji and has published in prestigious journals such as Journal of Hepatology, European Journal of Cancer and Clinical Pharmacokinetics.

In The Last Decade

Akinori Nagamitsu

10 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akinori Nagamitsu Japan	6	290	208	174	83	64	11	482
Henrike Caysa Germany	13	225 0.8×	211 1.0×	237 1.4×	115 1.4×	84 1.3×	15	662
Lucien Bildstein France	7	215 0.7×	208 1.0×	156 0.9×	67 0.8×	63 1.0×	8	462
Suo-Qin Tang China	12	241 0.8×	295 1.4×	208 1.2×	91 1.1×	58 0.9×	41	570
Shunan Wan China	6	199 0.7×	165 0.8×	173 1.0×	55 0.7×	64 1.0×	7	399
Hayley Nehoff New Zealand	3	272 0.9×	165 0.8×	221 1.3×	49 0.6×	66 1.0×	3	466
Lidia Mak Israel	9	395 1.4×	278 1.3×	232 1.3×	114 1.4×	51 0.8×	11	589
P. Vasey United Kingdom	4	359 1.2×	274 1.3×	200 1.1×	126 1.5×	42 0.7×	7	649
Aida Varela-Moreira Netherlands	12	274 0.9×	202 1.0×	149 0.9×	65 0.8×	48 0.8×	16	507
Kiran R. Chaudhari India	7	255 0.9×	253 1.2×	179 1.0×	129 1.6×	41 0.6×	8	529
Senat Krasnici Germany	7	255 0.9×	254 1.2×	171 1.0×	69 0.8×	27 0.4×	8	505

Countries citing papers authored by Akinori Nagamitsu

Since Specialization

Citations

This map shows the geographic impact of Akinori Nagamitsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akinori Nagamitsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akinori Nagamitsu more than expected).

Fields of papers citing papers by Akinori Nagamitsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akinori Nagamitsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akinori Nagamitsu. The network helps show where Akinori Nagamitsu may publish in the future.

Co-authorship network of co-authors of Akinori Nagamitsu

This figure shows the co-authorship network connecting the top 25 collaborators of Akinori Nagamitsu. A scholar is included among the top collaborators of Akinori Nagamitsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akinori Nagamitsu. Akinori Nagamitsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Maeda, Hajime, et al.. (2011). 987 TREATMENTS OF HEPATOMA AND OTHER ABDOMINAL CANCERS USING SMANCS/LIPIODOL GIVEN INTRAARTERIALLY UNDER ANGIOTENSIN-II INDUCED HIGH BLOOD-PRESSURE. Journal of Hepatology. 54. S393–S393. 1 indexed citations

Nagamitsu, Akinori, Khaled Greish, & Hiroshi Maeda. (2009). Elevating Blood Pressure as a Strategy to Increase Tumor-targeted Delivery of Macromolecular Drug SMANCS: Cases of Advanced Solid Tumors. Japanese Journal of Clinical Oncology. 39(11). 756–766. 136 indexed citations

Nagamitsu, Akinori, et al.. (2007). SMANCS dynamic therapy for various advanced solid tumors and promising clinical effects: enhanced drug delivery by hydrodynamic modulation with vascular mediators, particularly angiotensin II, during arterial infusion. Drug Delivery System. 22(5). 510–521. 5 indexed citations

Greish, Khaled, Akinori Nagamitsu, Jun Fang, & Hiroshi Maeda. (2004). Copoly(styrene-maleic acid)−Pirarubicin Micelles: High Tumor-Targeting Efficiency with Little Toxicity¹. Bioconjugate Chemistry. 16(1). 230–236. 85 indexed citations

Nagamitsu, Akinori, et al.. (2003). Recent advances in SMANCS/Lipiodol therapy-enhanced targeting and delivery efficacy using vascular modulators. Drug Delivery System. 18(5). 438–447. 3 indexed citations

Greish, Khaled, et al.. (2003). Macromolecular Therapeutics. Clinical Pharmacokinetics. 42(13). 1089–1105. 219 indexed citations

Nagamitsu, Akinori, et al.. (2002). Personalized targeting cancer chemotherapy with SMANCS/lipiodol and the points of this therapy.. Drug Delivery System. 17(2). 94–102. 1 indexed citations

Nagamitsu, Akinori, et al.. (1998). Targeted cancer chemotherapy for VX2 tumour implanted in the colon with lipiodol as a carrier. European Journal of Cancer. 34(11). 1764–1769. 16 indexed citations

Oda, Takeshi, et al.. (1998). Targeted vinblastine chemotherapy with two preparations of lipiodol contrast medium.. PubMed. 17(5A). 3521–9. 2 indexed citations

10.

Konno, T, et al.. (1998). [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].. PubMed. 25 Suppl 1. 10–8. 2 indexed citations

11.

Konno, Toshimitsu, et al.. (1994). Targeted Chemotherapy for Unresectable Primary and Metastatic Liver Cancer. Acta Oncologica. 33(2). 133–137. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact